(Q40618792)

22 September 2017

1 reference

title

Maintenance of symptomatic remission in patients with Crohn's disease (English)

1 reference

22 September 2017

2

W J Tremaine

1 reference

22 September 2017

M E Stark

1

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 December 1993

1 reference

22 September 2017

1 reference

22 September 2017

volume

68

1 reference

22 September 2017

issue

12

1 reference

22 September 2017

page(s)

1183-1190

1 reference

Recurrence of Crohn's disease after resection

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

The long-term outcome of restorative operation in Crohn's disease: influence of location, prognostic factors and surgical guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Surgical management of Crohn's disease. Influence of disease at margin of resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. The Italian IBD Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Postoperative recurrence of Crohn's disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Reoperation and recurrence in Crohn's colitis and ileocolitis Crude and cumulative rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Low dose steroids and clinical relapse in Crohn's disease: a controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn's disease. A controlled double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

The possible utility of steroids in the prevention of relapses of Crohn's disease in remission. A preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Sulphasalazine in asymptomatic Crohn's disease. A multicentre trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Long-term immunosuppressive treatment in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Controlled trial of azathioprine in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

A controlled trial of azathioprine in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Final report on a placebo-controlled, double-blind, randomized, multicentre trial of cyclosporin treatment in active chronic Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Treatment of Crohn's disease in relapse with cyclosporin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Cyclosporin A treatment in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Elemental diet as primary treatment of acute Crohn's disease: a controlled trial

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

7 January 2021

Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Remission induced by an elemental diet in small bowel Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Elemental diets in treatment of acute Crohn's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Continuous elemental enteral alimentation in the treatment of children and adolescents with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Crohn's disease: maintenance of remission by diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Vitamin A therapy in patients with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Selective 5-lipoxygenase inhibition in ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Multiple blood transfusions reduce the recurrence rate of Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Blood transfusion and recurrent Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Predictors of acute relapse of Crohn's disease. A laboratory and clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Usefulness of fecal alpha 1-antitrypsin clearance and fecal concentration as early indicator of postoperative asymptomatic recurrence in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Maintenance of remission in ulcerative colitis with sulphasalazine or a high-fibre diet: a clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

Immunosuppressant therapy of inflammatory bowel disease. Pharmacologic and clinical aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

7 January 2021

Long-term treatment of Crohn's disease with cyclosporine: the effect of a very low dose on maintenance of remission.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

7 January 2021

Rifabutin and ethambutol do not help recurrent Crohn's disease in the neoterminal ileum

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960070-6

7 January 2021

10.1016/S0025-6196(12)60070-6

Identifiers

DOI

1 reference

22 September 2017

1 reference